Nexxen International Stock Price, News & Analysis

Nexxen (NASDAQ: NEXN) repurchased 412,088 shares at an average price of $6.18 during January 2026 and had 56,070,588 ordinary shares outstanding as of January 31, 2026. Approximately $5.0 million remains under the current authorization.

The company said it has authorization to begin a $40 million new share repurchase program after the current program ends; repurchased shares under the new program would be held as dormant treasury shares under Israeli law.

Nexxen (NEXN) released a 2026 FIFA World Cup predictions report using proprietary data and a 2025 U.S. consumer survey of 1,000+ adults to forecast viewing behavior for the expanded, North America-hosted tournament.

Key findings: U.S. soccer interest +48%, 43% plan to watch via streaming/vMVPDs (a 14% increase vs 2022), 87% would watch on free ad-supported streaming (FAST) if available, and 90% of intended viewers misidentify at least one platform carrying matches. Nexxen positions its SSP/DSP and Nexxen Sports to help advertisers reach fragmented audiences across screens.

Nexxen (NASDAQ: NEXN) announced board transitions following its January 6, 2026 Annual General Meeting.

The terms of directors Joanna Parnell (board member since 2014) and Norm Johnston (board member since June 2020) concluded, and the Board will now consist of six directors: one executive director and five non-executive directors. The Board plans to appoint a third independent director to the Audit Committee in the near term. The company said it does not anticipate any impact to operations or strategic direction from these governance changes.

Nexxen (NASDAQ: NEXN) repurchased 495,000 shares in December 2025 at an average price of $6.63. As of Dec 31, 2025, the company had 56,284,083 ordinary shares outstanding (excluding treasury) and about $7.5 million remaining under its current repurchase authorization.

The company received authorization, after a 30-day creditor objection period and lender consent, to begin a new share repurchase program of up to $40 million once the current program completes. Repurchased shares will be reclassified as dormant treasury shares without rights. The company said the program may be suspended, modified, or discontinued and will provide an update when the new program commences.

Nexxen (NASDAQ: NEXN) postponed its 2025 Annual General Meeting from December 30, 2025 to January 6, 2026 at 3:30 p.m. Israel time to allow shareholders more time to review the Amended and Restated Proxy Statement (Nov 26, 2025) and Supplemental Proxy Statement (Dec 26, 2025) and to accommodate market holidays.

The record date remains December 1, 2025. The voting deadline for the postponed AGM is extended to 11:59 p.m. EDT on January 5, 2026. Proxies must be received at Nexxen's offices at 82 Yigal Alon Street, Tel Aviv 6789124, Israel or by Computershare by the Voting Deadline to be counted. Previously submitted proxy cards remain valid unless replaced by a new submission. The Proxy Statement (as supplemented) is available on Nexxen's investor website and was furnished to the SEC on Form 6-K.

Nexxen (NASDAQ: NEXN) published a Supplemental Proxy Statement ahead of its 2025 Annual General Meeting scheduled for December 30, 2025. The supplement updates AGM proposals on board composition and compensation arrangements after shareholder input and was approved by the board to better align with shareholder interests.

The Supplemental Proxy Statement and AGM logistics are available in the Annual Reports & Circulars section of Nexxen's investor relations site and a copy has been furnished to the SEC on Form 6-K. The board recommends shareholders vote FOR all AGM proposals; previously submitted proxies remain valid unless replaced by a new submission.

Nexxen (NEXN) introduced measurement and optimization to Nexxen Health on Dec. 11, 2025, adding a first-to-market Auto Allocate feature in Nexxen DSP that uses real-time signals to shift ad spend toward high-quality audiences.

The update expands integration with PurpleLab to add real-world health intelligence from a large U.S. medical and pharmaceutical claims database, enables offline action data to drive dynamic budget optimization, and adds PurpleLab measurement and reporting for audience quality and script lift. The platform now combines targeting, activation, optimization and measurement for health and pharma campaigns while maintaining privacy compliance.

Nexxen (NEXN) launched Nexxen Sports on December 9, 2025, a suite combining premium live sports inventory with data-driven audience targeting, dynamic creative, and measurement across devices.

Key metrics from Nexxen research: 48% of Americans watch live sports, 85% of those tune in weekly or more, and 75% use a second device while watching. The product uses Nexxen's unified DSP and SSP, a new microsite for custom campaigns, turnkey packages for marquee events (including FIFA 2026 World Cup), and direct premium supply to enable retargeting and cross-screen campaigns.

Partners quoted include KINESSO and FanDuel Sports Network; FanDuel reports a 40% year-over-year lift from the partnership.

Nexxen (NASDAQ: NEXN) said members of its executive and investor relations team will attend the Raymond James TMT and Consumer Conference in New York on December 9, 2025.

The company will take part in a fireside chat at 8:40 AM ET on December 9, 2025, with a live webcast available in the Events and Presentations section of Nexxen’s investor relations website and a replay accessible for approximately one year. Investors can request meetings with management via their Raymond James representative.